Capitala Group Exits Investment in Optio Rx
November 11, 2020
Capitala Group announced it has exited its senior secured debt and minority equity investment in Optio Rx, a national owner and operator of specialty compounding pharmacies. The original investment was made in partnership with Cold Bore Capital and funded Optio Rx's roll-up of specialty pharmacies serving fertility, veterinary, dermatology, hormone replacement and hospice markets.
- Targets
- Optio Rx
- Sellers
- Capitala Group
- Industry
- Healthcare Services
- Location
- Tennessee, United States
- Transaction Type
- Divestiture
Explore More
Related Acquisitions
-
Cinven and La Caisse to Acquire Optio Group Specialty MGA Platform
July 27, 2026
Insurance
Cinven, alongside La Caisse, has agreed to acquire Optio Group, a UK-headquartered specialty insurance Managing General Agent (MGA) platform. The parties cite Optio’s capital-light underwriting model, structurally growing specialty insurance end market, and opportunities for continued organic and M&A growth, with the deal subject to regulatory approvals and customary closing conditions.
-
SK Capital Partners' Buyout and Recapitalization of Apotex Leading to IPO
June 10, 2026
Pharmaceuticals
SK Capital Partners acquired control of Apotex from the Sherman estate in 2023, then reoriented the business with cost cuts, geographic focus, and portfolio acquisitions (including biosimilars and specialty drugs). Over the following three years, SK Capital and the Sherman family completed a debt-heavy leveraged buyout and extracted roughly $2 billion via dividends and share repurchases, culminating in Apotex’s IPO in June 2026.
-
Cyprium Partners Invests in OneroRx
January 25, 2024
Healthcare Services
Cyprium Partners provided subordinated debt and minority common equity to OneroRx Inc., an integrated pharmacy services provider headquartered in West Des Moines, Iowa. The growth capital will support OneroRx’s acquisition-driven expansion across the Midwest—where the company operates roughly 65 locations and fills millions of prescriptions annually—and marks Cyprium’s 100th platform investment.
-
SK Capital affiliate acquires Apotex Pharmaceutical Holdings
April 3, 2023
Pharmaceuticals
An affiliate of funds advised by SK Capital Partners has acquired Apotex Pharmaceutical Holdings Inc. The acquisition closed on April 3, 2023.
-
One Equity Partners Completes Strategic Investment in InfuCare Rx
January 12, 2022
Healthcare Services
One Equity Partners (OEP) has completed a strategic investment in InfuCare Rx, a Fairfield, New Jersey–headquartered provider of specialty home infusion therapies and clinical therapy management. Financial terms were not disclosed; OEP said the capital will be used to accelerate growth, expand into new regions and scale InfuCare Rx's digital care management platform serving patients with complex chronic conditions.
-
Pouschine Cook Leads Investment in Curexa Pharmacy
December 4, 2021
Healthcare Services
Pouschine Cook Capital Management led a growth investment in Curexa Pharmacy, a PCAB-accredited 503A compounding pharmacy that partners with direct-to-consumer telemedicine brands. Institutional co-investors included ORIX Corporation USA’s Private Equity Solutions group and Hexagon; First Horizon Bank provided senior credit facilities and management completed a meaningful rollover to support continued scaling of Curexa’s digital and pharmacy infrastructure.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.